Authors: Colombat, P Salles, G Brousse, N Eftekhari, P Soubeyran, P Delwail, V Deconinck, E Haioun, C Foussard, C Sebban, C Stamatoullas, A Milpied, N Boue, F Taillan, B Lederlin, P Najman, A Thieblemont, C Montestruc, F Mathieu-Boue, A Benzohra, A Solal-Celigny, P

Citation: P. Colombat et al., Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy forpatients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation, BLOOD, 97(1), 2001, pp. 101-106

Authors: Milpied, N Vasseur, B Parquet, N Garnier, JL Antoine, C Quartier, P Carret, AS Bouscary, D Faye, A Bourbigot, B Reguerre, Y Stoppa, AM Bourquard, P de Ligny, BH Dubief, F Mathieu-Boue, A Leblond, V

Citation: N. Milpied et al., Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients, ANN ONCOL, 11, 2000, pp. 113-116